JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

A3859 Tariquidar methanesulfonate, hydrate

Target: P-glycoprotein (P-gp)

Summary: P-glycoprotein inhibitor, potent and selective

insoluble in H2O; insoluble in EtOH; ≥56.2 mg/mL
C5826 AG957

Summary: a tyrphostin that targets transforming Bcr-Abl fusion proteins
A8345 PF-562271 HCl

Target: FAK|Pyk2

Summary: FAK/Pyk2 inhibitor

≥26.35 mg/mL
N1841 Quercetin

Summary: Antitumor agent

insoluble in H2O; ≥15.1 mg/mL
A8326 AZD-5438

2 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK1/2/9 inhibitor

insoluble in H2O; ≥18.55 mg/mL
A4140 WP1066

Target: STAT|JAK

Summary: JAK2/STAT3 inhibitor,cell-permeable

insoluble in H2O; ≥17.8 mg/mL
A4428 PK 44 phosphate

Summary: DPP-IV inhibitor

<52.73 mg/mL
A4375 Anacetrapib (MK-0859)

1 Citation

Target: CETP

Summary: RhCETP/mutant CETP(C13S) inhibitor

≥31.9 mg/mL
B1577 C646

1 Citation

Target: p300

Summary: HAT p300-CBP inhibitor,cell-permeable

insoluble in H2O; ≥11.14 mg/mL
A8320 PF-00562271

Target: FAK|Pyk2

Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL